Render Target: STATIC
Render Timestamp: 2024-11-29T11:29:55.487Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-09-30 01:58:12.808
Product last modified at: 2024-09-30T08:01:02.451Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

Carboxymethyl/Carboxyethyl Lysine (E5C5H) Rabbit mAb #44358

Filter:
  • WB

    Supporting Data

    REACTIVITY All
    SENSITIVITY Endogenous
    MW (kDa)
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • All-All Species Expected 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    Carboxymethyl/Carboxyethyl Lysine (E5C5H) Rabbit mAb recognizes a broad range of carboxymethyl lysine (CML) and carboxyethyl lysine (CEL) containing proteins and peptides. This antibody does not cross-react with free CML or CEL and does not cross-react with proteins or peptides containing acetylated, succinylated, butyrylated, glutarylated, malonylated, or propionylated lysines.

    Species Reactivity:

    All Species Expected

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide containing CML/CEL flanked by degenerate amino acids at positions N- and C-terminal to the modified lysine.

    Background

    Carboxymethyl lysine (CML) and carboxyethyl lysine (CEL) are two protein post-translational modifications that arise from non-enzymatic pathways and represent examples of advanced glycation end products (AGEs) (1). The association between CML/CEL levels with glucose and oxidant stress levels underlies the use of these modifications as biomarkers for various disease conditions, including diabetes and osteoporosis (2). The Maillard reaction between monosaccharides and lysines can form a Schiff base intermediate that rearranges to become CML/CEL. In addition, fragmentation of the Schiff base intermediate and oxidation of amino acids and polyunsaturated fatty acids produce reactive species, such as glyoxal and methylglyoxal, which react with lysine to form CML/CEL. While CML/CEL exists as free and protein-incorporated forms, in vitro treatment with protein-incorporated CML/CEL in particular induces diverse effects, including reduced serotonin release in gastric cells, impaired calcium homeostasis in cardiac cells, and increased reactive oxygen intermediates in endothelial cells (3-5). These processes depend on receptor for AGE (RAGE) signaling.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.